NLRP3 and cardiac arrest: Consistent with these findings, we demonstrated that MCC950 showed benefit in improving survival, neurologic function, and lessening neuropathological injuries in post-cardiac arrest rats, indicating that MCC950 may target the NLRP3 inflammasome to prevent post-cardiac arrest brain damage.